Photo: Ceva Sante Animale
Photo: Ceva Sante Animale

Effects in the field of Gumboro control

Santé Animale
Ceva Santé Animale Company profile
18-03 | |
Photo: Ceva Sante Animale
Photo: Ceva Sante Animale

Gumboro is an acute and highly contagious viral infection. It manifests itself in birds by inflammation and subsequent atrophy of the bursa of Fabricius.

In this IBD Podcast episode, Christophe Cazaban is back to provide some additional explanations about the effects of Gumboro disease in the field. Together with host Marco-Aurelio Lopes, they will dive into the replication of the virus, the impact, and how to monitor the virus.

 

In collaboration with Ceva Santé Animale, Poultry World features its new podcast series ‘Ceva Poultry Sounds’. If you are a poultry professional or a producer working within the sector, this podcast series is for you!

Previous podcasts:

* How Gumboro vaccines work
* Gumboro worldwide epidemiology
* What is Gumboro disease and its impact on poultry
* New Gumboro disease finding, from the lab to the field

Santé Animale
Ceva Santé Animale Company profile

Ceva Santé Animale (Ceva) is the 5th global animal health company, led by experienced veterinarians, whose mission is to provide innovative health solutions for all animals to ensure the highest level of care and well-being. Our portfolio includes preventive medicine such as vaccines, pharmaceutical and animal welfare products for farm and companion animals, as well as equipment and services to provide the best experience for our customers. With 6,500 employees located in 47 countries, Ceva strives daily to bring to life its vision as a OneHealth company: “Together, beyond animal health”. 2022 turnover: €1.53 billion. Use the links below to learn more about Ceva.

Santé Animale
Ceva Santé Animale Company profile

Ceva Santé Animale (Ceva) is the 5th global animal health company, led by experienced veterinarians, whose mission is to provide innovative health solutions for all animals to ensure the highest level of care and well-being. Our portfolio includes preventive medicine such as vaccines, pharmaceutical and animal welfare products for farm and companion animals, as well as equipment and services to provide the best experience for our customers. With 6,500 employees located in 47 countries, Ceva strives daily to bring to life its vision as a OneHealth company: “Together, beyond animal health”. 2022 turnover: €1.53 billion. Use the links below to learn more about Ceva.